Los Angeles, USA, April 28, 2021 (GLOBE NEWSWIRE) -- Hereditary Deafness Market Expected to Rise by a CAGR of 4.09% by 2026, Claims DelveInsight
The Hereditary Deafness market is anticipated to surge due to an increasing prevalence of hearing loss patients and technological advancements.
DelveInsight’s Hereditary Deafness Market and Competitive Insight Report provides the current and forecast market and comprises Hereditary Deafness market trends and key competitors. DelveInsight estimated the market to grow at a high CAGR over the study period of 2018 – 2026.
Key Highlights of Hereditary Deafness Market report:
- Deafness can be transferred from parents to the child and can develop over time during childhood or adulthood. It can be autosomal recessive or dominant, X-linked, or mitochondrial-related. Almost 1% of all human genes are involved in the genetic hearing loss process. One may be born with a hearing loss know as congenital or may acquire it over time. It is estimated that around two-thirds of cases of childhood-onset hearing loss have a genetic cause.
- HiRes Ultra Cochlear Implant (Advanced Bionics), Cochlear™ Nucleus® system (Cochlear), BONEBRIDGE (MED-EL), Ponto 4 (Oticon Medical), Esteem® osseointegrated active middle ear implant (AMEI) (Envoy Medical), Venus Cochlear implant system (Nurotron Biotechnology) are some of the Hereditary Deafness devices available in the market. Most of these available devices are FDA-approved and are CE marked. Certain Hereditary Deafness emerging devices/therapeutics in the market comprise the Acclaim® Cochlear Implant (Envoy Medical), PIPE-505 (Pipeline Therapeutics, Inc.), DB-OTO (Decibel Therapeutics) and FX-322 (Frequency Therapeutics), among others.
- In December 2020, the FDA approved the premarket approval application (PMA) supplement for the Nucleus 24 Cochlear Implant System for expanding the indication to include infants aged 9–12 months with a bilateral, profound sensorineural hearing loss.
- In March 2020, Advanced Bionics announced a voluntary recall of the initial version of its HiRes Ultra and Ultra 3D cochlear implant devices due to a decrease in performance experienced by some recipients. The company developed several advances, comprising a new version of the device, to address the issue, and it received regulatory approval in the US and Europe for those improvements. It plans to submit the revisions to other regulatory agencies around the world.
- On June 29, 2020, Envoy Medical® Corporation announced that its fully implanted Acclaim® cochlear implant was granted the Breakthrough Device Designation from the FDA.
- In 2020, the FDA approved US MED-EL’s slim and lightweight RONDO 3 Audio Processor for the SYNCHRONY Cochlear Implant System.
- In December 2019, Cochlear Limited, the global leader in implantable hearing solutions, announced the US Food and Drug Administration (FDA) clearance of the Cochlear Osia 2 System.
Request for Sample @ Hereditary Deafness Competitive Landscape
Hereditary Deafness Treatment Market
According to the Centers for Disease Control and Prevention (CDC) data, about 6,500 U.S. infants born in 2017 were identified early with a permanent hearing loss. The prevalence of congenital hearing loss in 2017 was 1.7 per 1,000 babies screened for hearing loss. As per the study conducted by Romanov et al., the rate of congenitally deaf infants is generally considered to vary from 1 to 3 per 1,000 newborns in developed countries and up to 24 per 1,000 newborns in developing countries due to the higher presence of risk factors.
No drug-based therapy has been approved by the Food and Drug Administration (FDA). Hereditary Deafness treatment mainly relies on hearing aids, cochlear implants, bone induction implants and middle ear implants.
The Hereditary Deafness Market is estimated to increase due to advancements in healthcare technology, high healthcare expenditure, available reimbursement policies in developed countries, the growing population globally, and technological advancements are factors responsible for the growth of the Hereditary Deafness market size at a high CAGR during the forecast period.
Hereditary Deafness Key Players:
- Advanced Bionics
- Cochlear
- MED-EL GmbH
- Nurotron Biotechnology
- Oticon Medical
- Medtronic
- Envoy Medical
- Sonova
- Audina Hearing Instruments
- RION
- Decibel Therapeutics
- Frequency Therapeutics
- Pipeline Therapeutics, Inc.
Know more about the key companies involved @ Hereditary Deafness Market Key Companies
Table of Contents
| 1 | Hereditary Deafness Background and Overview |
| 2 | Hereditary Deafness Company Profiles |
| 3 | Hereditary Deafness Competitive Analysis |
| 4 | Hereditary Deafness Eligible Patient Pool Analysis (2018–2026) |
| 4.1 | Hereditary Deafness in the US |
| 4.2.1 | Hereditary Deafness in Germany |
| 4.2.2 | Hereditary Deafness in France |
| 4.2.3 | Hereditary Deafness in Spain |
| 4.2.4 | Hereditary Deafness in Italy |
| 4.2.5 | Hereditary Deafness in the UK |
| 4.3 | Hereditary Deafness in Japan |
| 5 | Hereditary Deafness Market Analysis in the 7MM (2018–2026) |
| 5.1 | Hereditary Deafness Market in the US |
| 5.2.1 | Hereditary Deafness Market in Germany |
| 5.2.2 | Hereditary Deafness Market in France |
| 5.2.3 | Hereditary Deafness Market in Italy |
| 5.2.4 | Hereditary Deafness Market in Spain |
| 5.2.5 | Hereditary Deafness Market in the United Kingdom |
| 5.3 | Hereditary Deafness Market Japan |
| 6 | Hereditary Deafness Market Drivers and Market Barriers |
| 7 | Hereditary Deafness SWOT Analysis |
The report offers valuable insight for clients venturing into Hereditary Deafness and acts as the trove of guidance for taking strategic business decisions in the field of Hereditary Deafness by giving a descriptive overview of pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies. The report has a thorough review of the market containing historical and Hereditary Deafness forecasted market size in 7MM.
DelveInsight’s analysts have prepared this report after a thorough secondary and primary research into the Hereditary Deafness market. Analysis and estimations are done by considering the share of top companies and industry expert viewpoints of Hereditary Deafness and eligible patient pool for Hereditary Deafness.
Visit to know more about the report offerings @ Hereditary Deafness Market Analysis
Related Reports
Deep Brain Stimulation Devices Pipeline Insight
DelveInsight’s “Deep Brain Stimulation Devices Pipeline Insight and Competitive Landscape, 2020” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the deep brain stimulation (DBS) devices pipeline landscape.
DelveInsight’s ‘Vagus Nerve Stimulator (VNS)-Market Insights, Competitive Landscape and Market Forecast-2025’ report delivers an in-depth understanding of Vagus Nerve Stimulators, historical and forecasted patient pool as well as the Vagus Nerve Stimulator market trends in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.
Patent Foramen Ovale Closure Devices Market
DelveInsight’s ‘Patent Foramen Ovale (PFO) Closure Devices-Market Insights, Competitive Landscape and Market Forecast-2025’ report delivers an in-depth understanding of the patent foramen ovale closure devices, historical and forecasted number of patients eligible for PFO closure as well as the patent foramen ovale closure devices market trends in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.
DelveInsight’s ‘Holter Monitor (HM)-Market Insights, Competitive Landscape and Market Forecast-2025’ report delivers an in-depth understanding of Holter monitor and the historical and forecasted Holter monitor market trends in the US EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.
DelveInsight’s ‘Defibrillator-Market Insights, Competitive Landscape and Market Forecast-2025’ report, deliver an in-depth understanding of Defibrillator and the historical and forecasted Defibrillator market trends in the US, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. It also proffers Competitive Intelligence Services that are specialized in customizing client projects and offer the best consulting advice and perspectives that are special and unique.